Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 12 | $123,246,520 |
Sells | 2 | $616,598 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
31 Oct 2023 17:00 | AMAM | Ambrx Biopharma Inc | NELSON SONJA | Chief Financial Officer | 27 Oct 2023 | Sale | 12,778 | 9.82 | 125,480 | D |
31 Oct 2023 17:00 | AMAM | Ambrx Biopharma Inc | O'CONNOR DANIEL J. | President and CEO | 27 Oct 2023 | Sale | 50,012 | 9.82 | 491,118 | D |
25 Oct 2023 16:15 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 23 Oct 2023 | Purchase | 1,307,311 | 6.9911 | 9,139,542 | I |
19 Sep 2023 16:49 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 18 Sep 2023 | Purchase | 751,233 | 9.2447 | 6,944,924 | I |
19 Sep 2023 16:49 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 15 Sep 2023 | Purchase | 1,401,505 | 9.0479 | 12,680,677 | I |
20 Apr 2023 18:04 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 20 Apr 2023 | Purchase | 886,634 | 11.6003 | 10,285,220 | I |
20 Apr 2023 18:04 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 19 Apr 2023 | Purchase | 951,909 | 11.1485 | 10,612,357 | I |
20 Apr 2023 18:04 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 18 Apr 2023 | Purchase | 3,376,646 | 11.2695 | 38,053,112 | I |
17 Apr 2023 17:46 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 17 Apr 2023 | Purchase | 562,121 | 10.6729 | 5,999,461 | I |
17 Apr 2023 17:46 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 14 Apr 2023 | Purchase | 841,967 | 9.958 | 8,384,307 | I |
17 Apr 2023 17:46 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 13 Apr 2023 | Purchase | 1,193,808 | 9.1602 | 10,935,520 | I |
16 Mar 2023 18:04 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 16 Mar 2023 | Purchase | 500,000 | 10.1485 | 5,074,250 | I |
16 Mar 2023 18:04 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 15 Mar 2023 | Purchase | 250,000 | 10.5955 | 2,648,875 | I |
16 Mar 2023 18:04 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 14 Mar 2023 | Purchase | 250,000 | 9.9531 | 2,488,275 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)